Advances in exosome-related biomarkers for glioblastoma: Basic research and clinical application

Advances in exosome-related biomarkers for glioblastoma: Basic research and clinical application

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults. The median survival rate of GBM patients is approximately 14 months and tumor recurrence is almost inevitable. With the increased use of immunotherapy, immune response and edema found on posttreatment magnetic...

Full description

Bibliographic Details
Main Authors: Yuzhen Jiang, Jiaying Qian, Jun Yang, Xiaoling Yan, Xiaoying Xue, Qing Chang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Glioma
Subjects:
Biomarker
clinical application
exosome
glioblastoma
tumor microenvironment
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=5;spage=159;epage=167;aulast=Jiang

Internet

http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=5;spage=159;epage=167;aulast=Jiang

Similar Items